{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T07:09:58Z","timestamp":1777619398412,"version":"3.51.4"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,2,25]],"date-time":"2015-02-25T00:00:00Z","timestamp":1424822400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1007\/s40263-015-0235-1","type":"journal-article","created":{"date-parts":[[2015,2,24]],"date-time":"2015-02-24T11:21:36Z","timestamp":1424776896000},"page":"221-227","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Pharmacotherapy of Acute Mania: Monotherapy or Combination Therapy with Mood Stabilizers and Antipsychotics?"],"prefix":"10.1007","volume":"29","author":[{"given":"Iria","family":"Grande","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduard","family":"Vieta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,2,25]]},"reference":[{"key":"235_CR1","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/bdi.12038","volume":"15","author":"LN Yatham","year":"2013","unstructured":"Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Beaulieu S, Alda M, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord. 2013;15:58\u201360.","journal-title":"Bipolar Disord."},{"key":"235_CR2","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3109\/15622975.2013.770551","volume":"14","author":"H Grunze","year":"2013","unstructured":"Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, M\u00f6ller H-J, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder. World J Biol Psychiatry. 2013;14:154\u2013219.","journal-title":"World J Biol Psychiatry."},{"key":"235_CR3","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1177\/0269881109102919","volume":"23","author":"GM Goodwin","year":"2009","unstructured":"Goodwin GM. Evidence-based guidelines for treating bipolar disorder: revised second edition\u2013recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2009;23:346\u201388.","journal-title":"J Psychopharmacol."},{"key":"235_CR4","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.euroneuro.2010.08.001","volume":"21","author":"JM Haro","year":"2011","unstructured":"Haro JM, Reed C, Gonzalez-Pinto A, Novick D, Bertsch J, Vieta E. 2-Year course of bipolar disorder type I patients in outpatient care: factors associated with remission and functional recovery. Eur Neuropsychopharmacol. 2011;21:287\u201393.","journal-title":"Eur Neuropsychopharmacol."},{"key":"235_CR5","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1017\/S1461145712000405","volume":"16","author":"I Grande","year":"2013","unstructured":"Grande I, de Arce R, Jim\u00e9nez-Arriero M\u00c1, Lorenzo FGI, Valverde JIF, Balanz\u00e1-Mart\u00ednez V, et al. Patterns of pharmacological maintenance treatment in a community mental health services bipolar disorder cohort study (SIN-DEPRES). Int J Neuropsychopharmacol. 2013;16:513\u201323.","journal-title":"Int J Neuropsychopharmacol."},{"key":"235_CR6","volume-title":"Manic-depressive illness: bipolar disorders and recurrent depression","author":"F Goodwin","year":"2007","unstructured":"Goodwin F, Jamison K. Manic-depressive illness: bipolar disorders and recurrent depression. 2nd ed. New York: Oxford University Press; 2007.","edition":"2"},{"key":"235_CR7","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Publishing; 2013.","edition":"5"},{"key":"235_CR8","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jad.2013.03.007","volume":"148","author":"E Vieta","year":"2013","unstructured":"Vieta E, Valent\u00ed M. Mixed states in DSM-5: implications for clinical care, education, and research. J Affect Disord. 2013;148:28\u201336.","journal-title":"J Affect Disord."},{"key":"235_CR9","volume-title":"Managing bipolar disorder in clinical practice","year":"2013","unstructured":"Vieta E, editor. Managing bipolar disorder in clinical practice. 3rd ed. London: Springer Healthcare; 2013.","edition":"3"},{"key":"235_CR10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jad.2011.10.015","volume":"140","author":"AMA Nivoli","year":"2012","unstructured":"Nivoli AMA, Murru A, Goikolea JM, Crespo JM, Montes JM, Gonz\u00e1lez-Pinto A, et al. New treatment guidelines for acute bipolar mania: a critical review. J Affect Disord. 2012;140:125\u201341.","journal-title":"J Affect Disord."},{"key":"235_CR11","doi-asserted-by":"crossref","unstructured":"Cipriani A, Barbui C, Salanti G, Rendell J, Brown R, Stockton S, et al. Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis. Lancet. Elsevier Ltd; 2011;378:1306\u201315.","DOI":"10.1016\/S0140-6736(11)60873-8"},{"key":"235_CR12","doi-asserted-by":"crossref","unstructured":"Yildiz A, Nikodem M, Vieta E, Correll CU, Baldessarini RJ. A network meta-analysis on comparative efficacy and all-cause discontinuation of antimanic treatments in acute bipolar mania. Psychol Med. (Epub 18 Jul 2014).","DOI":"10.1017\/S0033291714001305"},{"key":"235_CR13","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/npp.2010.192","volume":"36","author":"A Yildiz","year":"2011","unstructured":"Yildiz A, Vieta E, Leucht S, Baldessarini RJ. Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials. Neuropsychopharmacology. 2011;36:375\u201389.","journal-title":"Neuropsychopharmacology."},{"key":"235_CR14","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/HRP.0000000000000025","volume":"22","author":"A Yildiz","year":"2014","unstructured":"Yildiz A, Vieta E, Correll CU, Nikodem M, Baldessarini RJ. Critical issues on the use of network meta-analysis in psychiatry. Harv Rev Psychiatry. 2014;22:367\u201372.","journal-title":"Harv Rev Psychiatry."},{"key":"235_CR15","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1017\/S1461145713001168","volume":"17","author":"I Grande","year":"2013","unstructured":"Grande I, Bernardo M, Bobes J, Saiz-Ruiz J, Alamo C, Vieta E, et al. Antipsychotic switching in bipolar disorders: a systematic review. Int J Neuropsychopharmacol. 2013;17:497\u2013507.","journal-title":"Int J Neuropsychopharmacol."},{"key":"235_CR16","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.euroneuro.2012.05.017","volume":"23","author":"JM Goikolea","year":"2013","unstructured":"Goikolea JM, Colom F, Capapey J, Torres I, Valenti M, Grande I, et al. Faster onset of antimanic action with haloperidol compared to second-generation antipsychotics: a meta-analysis of randomized clinical trials in acute mania. Eur Neuropsychopharmacol. 2013;23:305\u201316.","journal-title":"Eur Neuropsychopharmacol."},{"key":"235_CR17","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jad.2012.07.038","volume":"144","author":"JM Goikolea","year":"2013","unstructured":"Goikolea JM, Colom F, Torres I, Capapey J, Valent\u00ed M, Undurraga J, et al. Lower rate of depressive switch following antimanic treatment with second-generation antipsychotics versus haloperidol. J Affect Disord. 2013;144:191\u20138.","journal-title":"J Affect Disord."},{"key":"235_CR18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-0447.2007.01056.x","volume":"434","author":"GS Sachs","year":"2007","unstructured":"Sachs GS, Gardner-Schuster EE. Adjunctive treatment of acute mania: a clinical overview. Acta Psychiatr Scand Suppl. 2007;434:27\u201334.","journal-title":"Acta Psychiatr Scand Suppl."},{"key":"235_CR19","doi-asserted-by":"crossref","first-page":"509","DOI":"10.4088\/JCP.v67n0401","volume":"67","author":"RH Perlis","year":"2006","unstructured":"Perlis RH, Welge JA, Vornik LA, Hirschfeld RMA, Keck PE. Atypical antipsychotics in the treatment of mania: a meta-analysis of randomized, placebo-controlled trials. J Clin Psychiatry. 2006;67:509\u201316.","journal-title":"J Clin Psychiatry."},{"key":"235_CR20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4088\/JCP.v61n0104","volume":"61","author":"MA Frye","year":"2000","unstructured":"Frye MA, Ketter TA, Leverich GS, Huggins T, Lantz C, Denicoff KD, et al. The increasing use of polypharmacotherapy for refractory mood disorders: 22\u00a0years of study. J Clin Psychiatry. 2000;61:9\u201315.","journal-title":"J Clin Psychiatry."},{"key":"235_CR21","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1176\/ps.2006.57.5.660","volume":"57","author":"SN Ghaemi","year":"2006","unstructured":"Ghaemi SN, Hsu DJ, Thase ME, Wisniewski SR, Nierenberg AA, Miyahara S, et al. Pharmacological treatment patterns at study entry for the first 500 STEP-BD participants. Psychiatr Serv. 2006;57:660\u20135.","journal-title":"Psychiatr Serv."},{"key":"235_CR22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jad.2006.08.017","volume":"99","author":"M Wolfsperger","year":"2007","unstructured":"Wolfsperger M, Greil W, R\u00f6ssler W, Grohmann R. Pharmacological treatment of acute mania in psychiatric in-patients between 1994 and 2004. J Affect Disord. 2007;99:9\u201317.","journal-title":"J Affect Disord."},{"key":"235_CR23","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1017\/S1461145713000953","volume":"17","author":"GS Sachs","year":"2014","unstructured":"Sachs GS, Peters AT, Sylvia L, Grunze H. Polypharmacy and bipolar disorder: what\u2019s personality got to do with it? Int J Neuropsychopharmacol. 2014;17:1053\u201361.","journal-title":"Int J Neuropsychopharmacol."},{"key":"235_CR24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jad.2007.05.009","volume":"106","author":"E Vieta","year":"2008","unstructured":"Vieta E, Panicali F, Goetz I, Reed C, Comes M, Tohen M. Olanzapine monotherapy and olanzapine combination therapy in the treatment of mania: 12-week results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) observational study. J Affect Disord. 2008;106:63\u201372.","journal-title":"J Affect Disord."},{"key":"235_CR25","first-page":"1","volume":"13","author":"E Vieta","year":"2013","unstructured":"Vieta E, Langosch JM, Figueira ML, Souery D, Blasco-Colmenares E, Medina E, et al. Clinical management and burden of bipolar disorder: results from a multinational longitudinal study (WAVE-bd). Int J Neuropsychopharmacol. 2013;13:1\u201314.","journal-title":"Int J Neuropsychopharmacol."},{"issue":"Suppl 5","key":"235_CR26","first-page":"9","volume":"69","author":"TA Ketter","year":"2008","unstructured":"Ketter TA. Monotherapy versus combined treatment with second-generation antipsychotics in bipolar disorder. J Clin Psychiatry. 2008;69(Suppl 5):9\u201315.","journal-title":"J Clin Psychiatry."},{"key":"235_CR27","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1600-0447.2006.00912.x","volume":"115","author":"LA Smith","year":"2007","unstructured":"Smith LA, Cornelius V, Warnock A, Tacchi MJ, Taylor D. Acute bipolar mania: a systematic review and meta-analysis of co-therapy vs. monotherapy. Acta Psychiatr Scand. 2007;115:12\u201320.","journal-title":"Acta Psychiatr Scand."},{"key":"235_CR28","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1001\/archpsyc.64.4.442","volume":"64","author":"H Scherk","year":"2007","unstructured":"Scherk H, Pajonk FG, Leucht S. Second-generation antipsychotic agents in the treatment of acute mania: a systematic review and meta-analysis of randomized controlled trials. Arch Gen Psychiatry. 2007;64:442\u201355.","journal-title":"Arch Gen Psychiatry."},{"issue":"11","key":"235_CR29","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s40263-014-0197-8","volume":"28","author":"Y Ogawa","year":"2014","unstructured":"Ogawa Y, Tajika A, Takeshima N, Hayasaka Y, Furukawa TA. Mood stabilizers and antipsychotics for acute mania: a systematic review and meta-analysis of combination\/augmentation therapy versus monotherapy. CNS Drugs. 2014;28(11):989\u20131003.","journal-title":"CNS Drugs."},{"key":"235_CR30","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/YIC.0b013e328080ca57","volume":"22","author":"LN Yatham","year":"2007","unstructured":"Yatham LN, Vieta E, Young AH, M\u00f6ller H-J, Paulsson B, V\u00e5ger\u00f6 M. A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania. Int Clin Psychopharmacol. 2007;22:212\u201320.","journal-title":"Int Clin Psychopharmacol."},{"key":"235_CR31","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1399-5618.2004.00115.x","volume":"6","author":"G Sachs","year":"2004","unstructured":"Sachs G, Chengappa KNR, Suppes T, Mullen JA, Brecher M, Devine NA, et al. Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study. Bipolar Disord. 2004;6:213\u201323.","journal-title":"Bipolar Disord."},{"key":"235_CR32","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/01.jcp.0000144887.66319.2f","volume":"24","author":"LN Yatham","year":"2004","unstructured":"Yatham LN, Paulsson B, Mullen J, V\u00e5ger\u00f6 AM. Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar mania. J Clin Psychopharmacol. 2004;24:599\u2013606.","journal-title":"J Clin Psychopharmacol."},{"key":"235_CR33","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1192\/bjp.182.2.141","volume":"182","author":"LN Yatham","year":"2003","unstructured":"Yatham LN, Grossman F, Augustyns I, Vieta E, Ravindran A. Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial. Br J Psychiatry. 2003;182:141\u20137.","journal-title":"Br J Psychiatry."},{"key":"235_CR34","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1176\/appi.ajp.159.7.1146","volume":"159","author":"GS Sachs","year":"2002","unstructured":"Sachs GS, Grossman F, Ghaemi SN, Okamoto A, Bowden CL. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety. Am J Psychiatry. 2002;159:1146\u201354.","journal-title":"Am J Psychiatry."},{"key":"235_CR35","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jad.2010.09.011","volume":"129","author":"J Berwaerts","year":"2011","unstructured":"Berwaerts J, Lane R, Nuamah IF, Lim P, Remmerie B, Hough DW. Paliperidone extended-release as adjunctive therapy to lithium or valproate in the treatment of acute mania: a randomized, placebo-controlled study. J Affect Disord. 2011;129:252\u201360.","journal-title":"J Affect Disord."},{"key":"235_CR36","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1399-5618.2010.00815.x","volume":"12","author":"E Vieta","year":"2010","unstructured":"Vieta E, Nuamah IF, Lim P, Yuen EC, Palumbo JM, Hough DW, et al. A randomized, placebo- and active-controlled study of paliperidone extended release for the treatment of acute manic and mixed episodes of bipolar I disorder. Bipolar Disord. 2010;12:230\u201343.","journal-title":"Bipolar Disord."},{"key":"235_CR37","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0165-0327(80)90029-4","volume":"2","author":"PE Garfinkel","year":"1980","unstructured":"Garfinkel PE, Stancer HC, Persad E. A comparison of haloperidol, lithium carbonate and their combination in the treatment of mania. J Affect Disord. 1980;2:279\u201388.","journal-title":"J Affect Disord."},{"key":"235_CR38","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1600-0447.2008.01204.x","volume":"118","author":"C Torrent","year":"2008","unstructured":"Torrent C, Amann B, S\u00e1nchez-Moreno J, Colom F, Reinares M, Comes M, et al. Weight gain in bipolar disorder: pharmacological treatment as a contributing factor. Acta Psychiatr Scand. 2008;118:4\u201318.","journal-title":"Acta Psychiatr Scand."},{"key":"235_CR39","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/archpsyc.59.1.62","volume":"59","author":"M Tohen","year":"2002","unstructured":"Tohen M, Chengappa KNR, Suppes T, Zarate CAJ, Calabrese JR, Bowden CL, et al. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Arch Gen Psychiatry. 2002;59:62\u20139.","journal-title":"Arch Gen Psychiatry."},{"key":"235_CR40","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.4088\/JCP.08m04895yel","volume":"70","author":"JP Houston","year":"2009","unstructured":"Houston JP, Tohen M, Degenhardt EK, Jamal HH, Liu LLL, Ketter TA. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study. J Clin Psychiatry. 2009;70:1540\u20137.","journal-title":"J Clin Psychiatry."},{"key":"235_CR41","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1192\/bjp.bp.107.041301","volume":"192","author":"M Tohen","year":"2008","unstructured":"Tohen M, Bowden CL, Smulevich AB, Bergstrom R, Quinlan T, Osuntokun O, et al. Olanzapine plus carbamazepine v. carbamazepine alone in treating manic episodes. Br J Psychiatry J Ment Sci. 2008;192:135\u201343.","journal-title":"Br J Psychiatry J Ment Sci."},{"key":"235_CR42","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1176\/appi.ajp.2008.07101560","volume":"165","author":"E Vieta","year":"2008","unstructured":"Vieta E, T\u2019joen C, McQuade RD, Carson WHJ, Marcus RN, Sanchez R, et al. Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate\/lithium monotherapy: a placebo-controlled study. Am J Psychiatry. 2008;165:1316\u201325.","journal-title":"Am J Psychiatry."},{"key":"235_CR43","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.4088\/JCP.11m07388","volume":"73","author":"GS Sachs","year":"2012","unstructured":"Sachs GS, Vanderburg DG, Karayal ON, Kolluri S, Bachinsky M, Cavus I. Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 1: results of a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2012;73:1412\u20139.","journal-title":"J Clin Psychiatry."},{"key":"235_CR44","doi-asserted-by":"crossref","first-page":"130","DOI":"10.4088\/JCP.09m05482yel","volume":"71","author":"CL Bowden","year":"2010","unstructured":"Bowden CL, Vieta E, Ice KS, Schwartz JH, Wang PP, Versavel M. Ziprasidone plus a mood stabilizer in subjects with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind trial. J Clin Psychiatry. 2010;71:130\u20137.","journal-title":"J Clin Psychiatry."},{"key":"235_CR45","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/JCP.0b013e31823f872f","volume":"32","author":"A Szegedi","year":"2012","unstructured":"Szegedi A, Calabrese JR, Stet L, Mackle M, Zhao J, Panagides J. Asenapine as adjunctive treatment for acute mania associated with bipolar disorder: results of a 12-week core study and 40-week extension. J Clin Psychopharmacol. 2012;32:46\u201355.","journal-title":"J Clin Psychopharmacol."},{"key":"235_CR46","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00004714-200004000-00012","volume":"20","author":"B M\u00fcller-Oerlinghausen","year":"2000","unstructured":"M\u00fcller-Oerlinghausen B, Retzow A, Henn FA, Giedke H, Walden J. Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania: a prospective, randomized, double-blind, placebo-controlled, multicenter study. European Valproate Mania Study Group. J Clin Psychopharmacol. 2000;20:195\u2013203.","journal-title":"J Clin Psychopharmacol."},{"key":"235_CR47","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/00004714-199912000-00003","volume":"19","author":"JC Chou","year":"1999","unstructured":"Chou JC, Czobor P, Charles O, Tuma I, Winsberg B, Allen MH, et al. Acute mania: haloperidol dose and augmentation with lithium or lorazepam. J Clin Psychopharmacol. 1999;19:500\u20135.","journal-title":"J Clin Psychopharmacol."},{"key":"235_CR48","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0278-5846(89)90009-2","volume":"13","author":"HJ M\u00f6ller","year":"1989","unstructured":"M\u00f6ller HJ, Kissling W, Riehl T, B\u00e4uml J, Binz U, Wendt G. Doubleblind evaluation of the antimanic properties of carbamazepine as a comedication to haloperidol. Prog Neuropsychopharmacol Biol Psychiatry. 1989;13:127\u201336.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry."},{"key":"235_CR49","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1755-5949.2011.00260.x","volume":"18","author":"RW Licht","year":"2012","unstructured":"Licht RW. Lithium: still a major option in the management of bipolar disorder. CNS Neurosci Ther. 2012;18:219\u201326.","journal-title":"CNS Neurosci Ther."},{"key":"235_CR50","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.euroneuro.2009.04.003","volume":"19","author":"G Goodwin","year":"2009","unstructured":"Goodwin G, Fleischhacker W, Arango C, Baumann P, Davidson M, de Hert M, et al. Advantages and disadvantages of combination treatment with antipsychotics. ECNP Consensus Meeting, March 2008, Nice. Eur Neuropsychopharmacol. 2009;19:520\u201332.","journal-title":"Eur Neuropsychopharmacol."},{"key":"235_CR51","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.eurpsy.2010.09.012","volume":"26","author":"A Murru","year":"2011","unstructured":"Murru A, Colom F, Nivoli A, Pacchiarotti I, Valenti M, Vieta E. When should mood stabilizers be withdrawn due to lack of efficacy? Some methodological considerations. Eur Psychiatry. 2011;26:183\u20136.","journal-title":"Eur Psychiatry."},{"key":"235_CR52","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.euroneuro.2011.09.008","volume":"22","author":"D Popovic","year":"2012","unstructured":"Popovic D, Reinares M, Goikolea JM, Bonnin CM, Gonzalez-Pinto A, Vieta E. Polarity index of pharmacological agents used for maintenance treatment of bipolar disorder. Eur Neuropsychopharmacol. 2012;22:339\u201346.","journal-title":"Eur Neuropsychopharmacol."}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-015-0235-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40263-015-0235-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-015-0235-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T05:46:28Z","timestamp":1566366388000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40263-015-0235-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,25]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["235"],"URL":"https:\/\/doi.org\/10.1007\/s40263-015-0235-1","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,25]]}}}